5 Easy Facts About ABBV-744 combination therapy with chemotherapy Described
These side effects were being notably milder when compared to an inhibitor of the two bromodomains. A detailed molecular Assessment also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor88 These preclinical studies supply paradigms for long run clinical trials in AML, and